In last trading session, Inhibikase Therapeutics Inc (NASDAQ:IKT) saw 0.1 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price
In the last trading session, 0.2 million shares of the Inhibikase Therapeutics Inc (NASDAQ:IKT) were traded, and its beta was 1.12. Most recently the company’s
During the last session, Inhibikase Therapeutics Inc (NASDAQ:IKT)’s traded shares were 0.34 million, with the beta value of the company hitting 1.16. At the end
Inhibikase Therapeutics Inc (NASDAQ:IKT)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 1.18. At the close of
In the last trading session, 1.57 million Inhibikase Therapeutics Inc (NASDAQ:IKT) shares changed hands as the company’s beta touched 1.15. With the company’s per share
In recent trading session, Inhibikase Therapeutics Inc (NASDAQ:IKT) saw 0.9 million shares changing hands at last check today with its beta currently measuring 1.15. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
